Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) for patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is much more intensive than multi-agent combined chemotherapy, although allogeneic HSCT is associated wit...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Nagafuji, Koji, Miyamoto, Toshihiro, Eto, Tetsuya, Kamimura, Tomohiko, Taniguchi, Shuichi, Okamura, Takashi, Ohtsuka, Eiichi, Yoshida, Takashi, Higuchi, Masakazu, Yoshimoto, Goichi, Fujisaki, Tomoaki, Abe, Yasunobu, Takamatsu, Yasushi, Yokota, Shouhei, Akashi, Koichi, Harada, Mine
Format:	Artigo
Sprog:	Inglês
Udgivet:	BioMed Central 2013
Fag:	Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3574830/ https://ncbi.nlm.nih.gov/pubmed/23388549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-14
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

Lignende værker